Drug
Vonsetamig clinical trials
Also written REGN5459.
- studies test it
- 3
- open now
- 1
- in phase 3
- 0
- first study started
- 2019
Keep track of what changes. Save the vonsetamig studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
3 studies that test it; most in 2019 (1)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2022 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses vonsetamig is read from its arms, and is right about nine times in ten.
Testing it · 3
- Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus NephritisRecruitingPhase 1Regeneron PharmaceuticalsNCT06975787Written as Vonsetamig
- A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)Active, not recruitingPhase 1/2Regeneron PharmaceuticalsNCT05092347Written as Vonsetamig
- First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)CompletedPhase 1/2Regeneron PharmaceuticalsNCT04083534Written as REGN5459
Codes
What other systems call vonsetamig · ClinicalTrials.gg INT014565
- UNII (FDA) 30WLL6DR9OVONSETAMIGOne source FDA
- NCI Thesaurus C199130VonsetamigOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 30WLL6DR9O | VONSETAMIG | One source FDA |
| NCI Thesaurus | C199130 | Vonsetamig | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.